Kim Schenk

Vice President

Ms. Schenk has provided damages analysis and expert witness testimony intellectual property litigation in a wide variety of industries, including Communications & Media, Life Sciences, and Consumer Products.

Her experience includes quantifying lost profits, reasonable royalties, price erosion, and defendants’ profits. She has also evaluated commercial success as a secondary consideration of nonobviousness and irreparable harm in the context of injunctions. Ms. Schenk has testified as an expert witness more than twenty matters in Federal Court, including a number of intellectual property trials.

In addition to her experience in intellectual property matters, Ms. Schenk has performed damages assessments for a variety of other types of business disputes, including Lanham Act matters, breach of contract litigation, and general commercial disputes. She has been involved in valuations of privately held businesses, patents and patent portfolios, trademarks, non-competition agreements, and other intangible assets. She also managed several large business valuation projects in the context of estate tax and transfer pricing disputes.

Ms. Schenk was named to the IAM Patent 1000: The World’s Leading Patent Professionals in 2019 and 2020.

Ms. Schenk is a Certified Public Accountant (CPA) in the state of Illinois, and she is Certified in Financial Forensics (CFF) by the American Institute of Certified Public Accountants.

Selected Engagements

  • 01
    Federal Circuit affirms $107 million judgment in patent case based on expert’s testimony
    The ‘991 patent covers a drug formulation that uses magnesium stearate combined with an active ingredient to form composite active particles that improve the...
    View engagement
  • 02
    CRA Expert Provides Trial Testimony Regarding Surgical Technique
    A CRA expert testified at trial regarding the amount of reasonable royalties due to a spine surgeon as a result of the infringement of his patents by a major...
    View engagement
  • 03
    Damages testimony in Federal Court of Canada for antibiotic drug patent
    CRA provided expert testimony on patent damages on behalf of plaintiffs Eli Lilly in a patent infringement trial in the Federal Court of Canada. The patents...
    View engagement